NEW YORK (GenomeWeb News) – Aston University, in Birmingham, UK, will collaborate in an EU-funded study aimed at finding biomarkers for human aging. Scientists at Aston's School of Life and Health Sciences will conduct proteomics studies of blood samples to find biomarkers related to aging for the MARK-AGE study, which is a five-year study funded with €12 million ($17.1 million) under the Seventh Research Framework Programme.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.